Celaid Therapeutics has long been working in collaboration with BRI (Foundation for Biomedical Research and Innovation at Kobe), which is active in supporting corporate activities in the field of regenerative medicine.
The Kobe Office has now been established as a new base of operations in International Medical Device Alliance Center (IMDA) within the Kobe Biomedical Innovation Cluster (KBIC), for the purpose of searching for companies and CVCs in the Kansai region and to further promote collaboration.
